## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the
Head and neck squamous cell carcinoma in patients aged ≥80 years : Patterns of care and survival
✍ Scribed by Antoine Italiano; Cecile Ortholan; Olivier Dassonville; Gilles Poissonnet; Juliette Thariat; Karen Benezery; Jacques Vallicioni; Frédéric Peyrade; Pierre-Yves Marcy; René-Jean Bensadoun
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 193 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background We have shown that rIL‐2 administration in recurrent head and neck cancers induces a tumor‐specific T‐lymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5‐fluorouracil. Long‐term results
## Background: Elderly patients over 80 years of age represent a growing population, some of whom have complex medical problems that are compounded by the presence of upper aerodigestive tract cancer. ## Methods: Forty-three patients, aged 80 years and older, who were initially seen with head and
## Abstract ## Background For patients with head and neck cancer who were treated using primary radiotherapeutic approaches, the pattern of pathologic residual carcinoma in the neck dissection specimen and its effect on clinical outcome remains unknown. ## Methods Medical records of 65 patients